Gynecology/Obstetrics News

The FDA in 2023 approved treatments for several hospital-associated infections and fully approved a long-used COVID-19 medication, among other non-vaccine-related regulatory decisions.

SAN DIEGO — In patients with chronic rheumatic inflammatory disease, those who continue TNF inhibition during pregnancy have similar obstetrical outcomes as those who cease treatment, according to data presented at ACR Convergence 2023.

Come the new year, a “mini” pill could have a massive impact in rheumatology care.

Hormone therapy with transdermal estradiol may benefit bone and CV health and overall quality of life up to 20 years after hysterectomy, according to study results published in Menopause.

NEW YORK — An expert encouraged providers to “double our efforts” to prevent congenital syphilis.

SAN DIEGO — Pregnant patients with vasculitis demonstrate an increased frequency of spontaneous abortion and preterm delivery vs. healthy controls, according to data presented at ACR Convergence 2023.

Stressful life experiences, such as adverse childhood experiences, were not associated with age at natural menopause despite a negative impact of stress on the health of midlife women, researchers reported in Menopause.

SAN DIEGO — Pregnant patients with very low anti-Ro antibody titers of less than 1,000 units per mL have minimal-to-no risk for fetal atrioventricular block, according to data presented at ACR Convergence 2023.

Cases of congenital syphilis increased more than 10-fold between 2012 and 2022, the CDC reported Tuesday in another warning about the worsening epidemic of sexually transmitted infections in the United States.

HPV detectability was associated with better clinical cervical cancer prognosis vs. no detectable virus with up to a 41% lower mortality risk, according to a systematic review and meta-analysis published in Obstetrics & Gynecology.